Literature DB >> 29664767

The Proportion of Young Women Tested for Chlamydia Who Had Urogenital Symptoms in Physician Offices.

Chirag G Patel, Shivika Trivedi1, Guoyu Tao.   

Abstract

Using National Ambulatory Medical Care Survey data from 2006 to 2015, we estimated the proportions of young women tested for chlamydia who were symptomatic (urogenital symptoms) or asymptomatic in physician offices. Among women tested for chlamydia, the proportions of women with and without urogenital symptoms were 31.6% and 59.2%, respectively.

Entities:  

Mesh：

Year:  2018        PMID： 29664767      PMCID： PMC6823598          DOI： 10.1097/OLQ.0000000000000858

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


  16 in total

1.  Missed opportunities for chlamydia screening of young women in the United States.

Authors:  Karen Hoover; Guoyu Tao
Journal:  Obstet Gynecol       Date:  2008-05       Impact factor: 7.661

2.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 3.  Screening for chlamydial infection: an evidence update for the U.S. Preventive Services Task Force.

Authors:  David S Meyers; Heather Halvorson; Sara Luckhaupt
Journal:  Ann Intern Med       Date:  2007-06-18       Impact factor: 25.391

4.  Low rates of both asymptomatic chlamydia screening and diagnostic testing of women in US outpatient clinics.

Authors:  Karen Hoover; Guoyu Tao; Charlotte Kent
Journal:  Obstet Gynecol       Date:  2008-10       Impact factor: 7.661

5.  Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.

Authors:  Pippa Oakeshott; Sally Kerry; Adamma Aghaizu; Helen Atherton; Sima Hay; David Taylor-Robinson; Ian Simms; Phillip Hay
Journal:  BMJ       Date:  2010-04-08

6.  National Ambulatory Medical Care Survey: 2006 summary.

Authors:  Donald K Cherry; Esther Hing; David A Woodwell; Elizabeth A Rechtsteiner
Journal:  Natl Health Stat Report       Date:  2008-08-06

7.  Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement.

Authors:  Michael L LeFevre
Journal:  Ann Intern Med       Date:  2014-12-16       Impact factor: 25.391

8.  Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.

Authors:  L Weström; R Joesoef; G Reynolds; A Hagdu; S E Thompson
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

9.  Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.

Authors:  D Scholes; A Stergachis; F E Heidrich; H Andrilla; K K Holmes; W E Stamm
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

10.  Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012.

Authors:  Elizabeth Torrone; John Papp; Hillard Weinstock
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-09-26       Impact factor: 17.586
View more
  1 in total

1.  A pilot clinical validation study of a self-collected vaginal swab device for the detection of chlamydia trachomatis in women.

Authors:  Michael Muljadi; Chao-Min Cheng; Chung-Yao Yang; Ting-Chang Chang; Ching-Ju Shen
Journal:  Front Bioeng Biotechnol       Date:  2022-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.